Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. Apellis Pharmaceuticals Inc shares valued at $4,543 were sold by Chopas James George on Mar 17 ’25. At $24.82 per share, Chopas James George sold 183 shares. The insider’s holdings dropped to 47,955 shares worth approximately $0.92 million following the completion of this transaction.
Also, Chopas James George purchased 183 shares, netting a total of over 4,543 in proceeds.
Before that, Watson David O. had sold 5,569 shares from its account. In a trade valued at $139,789, the General Counsel traded Apellis Pharmaceuticals Inc shares for $25.10 each. Upon closing the transaction, the insider’s holdings decreased to 5,569 shares, worth approximately $2.67 million.
As published in their initiating research note from Cantor Fitzgerald on April 29, 2025, Apellis Pharmaceuticals Inc [APLS] has been an Overweight and the price target has been revised to $44. Analysts at Goldman downgraded the stock from ‘”a Buy”‘ to ‘”a Neutral”‘ outlook in a report released in mid December. As of November 21, 2024, Morgan Stanley has initiated its “an Equal-weight” rating for APLS. Earlier on October 25, 2024, RBC Capital Mkts initiated its rating. Their recommendation was “a Sector perform” for APLS stock.
Analyzing APLS Stock Performance
During the last five days, there has been a surge of approximately 9.83%. Over the course of the year, Apellis Pharmaceuticals Inc shares have dropped approximately -39.80%. Shares of the company reached a 52-week high of $35.57 on 01/07/25 and a 52-week low of $16.98 on 04/25/25. A 50-day SMA is recorded $22.67, while a 200-day SMA reached $30.11.
Support And Resistance Levels for Apellis Pharmaceuticals Inc (APLS)
According to the 24-hour chart, there is a support level at 18.24, which, if violated, would cause prices to drop to 17.28. In the upper region, resistance lies at 19.69. The next price resistance is at 20.18. RSI (Relative Strength Index) is 43.76 on the 14-day chart, showing neutral technical sentiment. Moving Average Convergence Divergence (MACD) is at 0.16, which suggests the price will decrease in the coming days. Percent R is at 18.28%, indicating bullish price movement. Stochastics %K at holding indicates that the stock is to be held.
